Link Technologies names new chief executive officer

Link Technologies has announced the appointment of the experienced life science expert Dr David Ricketts as its new chief executive officer.

Dr Ricketts has more than 25 years of relevant industry experience, including time spent as chief executive of the Belgian firm Pharma Diagnostics and, most recently, the Edinburgh-based business FibromEd.

He has also spent five years as an interim manager and consultant, working with companies providing products and services to drug discovery firms such as Gentronix and Cyprotex. The new chief executive will take up the role on October 20th.

Meanwhile, current chief Dr John Bremner – who has been with the company since its inception – has announced his retirement. He will remain as an expert consultant for a transitional period, before retiring at the end of the year.

Dr Mike Gray, chief operating officer of Link, said: "John has been fundamental to the conception, birth and growth of Link for 25 years. His contribution has been immense and for that everyone at Link thanks him wholeheartedly."

Based in central Scotland, the firm manufactures reagents for oligonucleotide synthesis and has been operating since 1989.